| Revenue growth | Revenue de-grew 5% YoY; branded business up 8%. |
|---|---|
| Margins | Adjusted EBITDA margin improved 2% to 27% post-reset. |
| Demand visibility | Strong domestic branded demand; international visibility clouded by logistics. |
| Management confidence | Confident but cautious due to ongoing integration and reset phase. |
Growth
Revenue fell 5% to ₹904cr due to trade generic discontinuation; however, branded India business grew 8%.
Outlook
Management expects mid-teen growth to resume in India within 2-3 quarters; international recovery by Q2.
Risks
West Asia shipping disruptions and near-term revenue leakage from the trade generics exit remain key concerns.
Earnings Call filed with NSE, NSE: JBCHEPHARM. Summary written with AI assistance from the document.
More from J B Chemicals & Pharmaceuticals Ltd
All →Jb Chemicals & Pharmaceuticals Merger & Restructuring
JB Chemicals & Pharmaceuticals' amalgamation with Torrent Pharmaceuticals received NCLT sanction. The scheme will become effective upon filing with the Registrar of Companies.
Jb Chemicals & Pharmaceuticals Management Change
Pradeep Kumar Singh and Suresh Bhise retired from the company. These changes in senior management are effective from June 30, 2026.
Jb Chemicals & Pharmaceuticals Price Movement Clarification
JB Chemicals clarified its audited financial results to the exchange. The board-approved results were signed by a director as authorized.
Jb Chemicals & Pharmaceuticals Management Change
Mr. Bhushan Sachdev resigned as Executive Vice President – Supply Chain Management effective June 12, 2026. Investors should note the departure of a key supply chain executive.
Jb Chemicals & Pharmaceuticals Annual Report
JB Chemicals & Pharmaceuticals Limited filed its Business Responsibility and Sustainability Report for FY 2025-26. The report details company ESG performance, sustainability targets, and governance frameworks.
Jb Chemicals & Pharmaceuticals Annual Report
JB Chemicals & Pharmaceuticals filed its FY26 Business Responsibility and Sustainability Report. The filing highlights its ₹3889.89 Crore turnover and ESG progress for investor review.
- Value
- ₹3,890 Cr